{"transactions":[{"id":683946,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-08-18T22:02:40.000Z","date":"2026-08-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":22781,"price":79.86,"value":1819290.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 41,194 shares of Common Stock underlying the Reporting Person's RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 116 shares of the Issuer's Common Stock acquired by the Reporting Person on August 14, 2026 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":336529,"source":{"system":"sec-edgar","filing":"0001470831-26-000837","document":"wk-form4_1787090557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000837/wk-form4_1787090557.xml","form_type":"4"}},{"id":772615,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-05-19T20:30:14.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":3195,"price":65.9507,"value":210712.4865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $65.54  to $66.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":359194,"source":{"system":"sec-edgar","filing":"0001470831-26-000473","document":"wk-form4_1779222603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000473/wk-form4_1779222603.xml","form_type":"4"}},{"id":772614,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-05-19T20:30:14.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":10456,"price":64.8151,"value":677706.6856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $64.34 to $65.33 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":362389,"source":{"system":"sec-edgar","filing":"0001470831-26-000473","document":"wk-form4_1779222603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000473/wk-form4_1779222603.xml","form_type":"4"}},{"id":772613,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-05-19T20:30:14.000Z","date":"2026-05-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":22781,"price":66.13,"value":1506507.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 41,193 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":372845,"source":{"system":"sec-edgar","filing":"0001470831-26-000473","document":"wk-form4_1779222603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000473/wk-form4_1779222603.xml","form_type":"4"}},{"id":832567,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-03-20T20:33:58.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":59041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2026, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":395626,"source":{"system":"sec-edgar","filing":"0001470831-26-000304","document":"wk-form4_1774038836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000304/wk-form4_1774038836.xml","form_type":"4"}},{"id":897461,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T23:36:26.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":200,"price":75.38,"value":15076.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."}],"balance_after":336585,"source":{"system":"sec-edgar","filing":"0001470831-26-000184","document":"wk-form4_1771457784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000184/wk-form4_1771457784.xml","form_type":"4"}},{"id":897460,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T23:36:26.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":13400,"price":74.7068,"value":1001071.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $74.30 to $75.19 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":336785,"source":{"system":"sec-edgar","filing":"0001470831-26-000184","document":"wk-form4_1771457784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000184/wk-form4_1771457784.xml","form_type":"4"}},{"id":897459,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T23:36:26.000Z","date":"2026-02-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":18819,"price":75.25,"value":1416129.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 37,503 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":350185,"source":{"system":"sec-edgar","filing":"0001470831-26-000184","document":"wk-form4_1771457784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083126000184/wk-form4_1771457784.xml","form_type":"4"}},{"id":967939,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-12-16T23:25:44.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":13826,"price":75.15,"value":1039023.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,000 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":369004,"source":{"system":"sec-edgar","filing":"0001470831-25-000420","document":"wk-form4_1765927541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083125000420/wk-form4_1765927541.xml","form_type":"4"}},{"id":996144,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-11-19T00:28:59.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":6956,"price":66.8398,"value":464937.6488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $66.61 to $67.26 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":382830,"source":{"system":"sec-edgar","filing":"0001470831-25-000351","document":"wk-form4_1763512137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083125000351/wk-form4_1763512137.xml","form_type":"4"}},{"id":996143,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-11-19T00:28:59.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":9978,"price":66.1923,"value":660466.7694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $65.575 to $66.57 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":389786,"source":{"system":"sec-edgar","filing":"0001470831-25-000351","document":"wk-form4_1763512137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083125000351/wk-form4_1763512137.xml","form_type":"4"}},{"id":996142,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-11-19T00:28:59.000Z","date":"2025-11-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":21317,"price":66.39,"value":1415235.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,547 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":399764,"source":{"system":"sec-edgar","filing":"0001470831-25-000351","document":"wk-form4_1763512137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000147083125000351/wk-form4_1763512137.xml","form_type":"4"}},{"id":1058468,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-08-22T20:58:52.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":42237,"price":49.4846,"value":2090081.0502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $49.08 to $49.77 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":421081,"source":{"system":"sec-edgar","filing":"0000950170-25-111011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017025111011/ownership.xml","form_type":"4"}},{"id":1062200,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-08-19T23:40:20.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":1973,"price":50.9439,"value":100512.3147,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $50.83 to $50.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":463318,"source":{"system":"sec-edgar","filing":"0000950170-25-110274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017025110274/ownership.xml","form_type":"4"}},{"id":1062199,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-08-19T23:40:20.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":15380,"price":50.1437,"value":771210.106,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $49.76 to $50.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":465291,"source":{"system":"sec-edgar","filing":"0000950170-25-110274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017025110274/ownership.xml","form_type":"4"}},{"id":1062198,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-08-19T23:40:20.000Z","date":"2025-08-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":21317,"price":51.32,"value":1093988.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,547 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":480671,"source":{"system":"sec-edgar","filing":"0000950170-25-110274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017025110274/ownership.xml","form_type":"4"}},{"id":1140742,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-05-20T21:07:22.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":21317,"price":33.84,"value":721367.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,545 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":501988,"source":{"system":"sec-edgar","filing":"0000950170-25-075346","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017025075346/ownership.xml","form_type":"4"}},{"id":1194853,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2025-03-21T22:32:49.000Z","date":"2025-03-19","kind":"grant","planned":false,"acquired":true,"shares":109100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":523305,"source":{"system":"sec-edgar","filing":"0000950170-25-043403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017025043403/ownership.xml","form_type":"4"}},{"id":1260735,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-20T01:51:51.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":13782,"price":34.9,"value":480991.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,431 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":414205,"source":{"system":"sec-edgar","filing":"0000950170-25-023632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017025023632/ownership.xml","form_type":"4"}},{"id":1334272,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-12-13T00:00:03.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSU's have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":427987,"source":{"system":"sec-edgar","filing":"0000950170-24-135982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017024135982/ownership.xml","form_type":"4"}},{"id":1359803,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-11-19T23:13:27.000Z","date":"2024-11-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":17936,"price":23.72,"value":425441.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,432 shares of Common Stock underlying the Reporting Person's restricted stock units."}],"balance_after":377987,"source":{"system":"sec-edgar","filing":"0000950170-24-128903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017024128903/ownership.xml","form_type":"4"}},{"id":1427944,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-08-20T22:24:17.000Z","date":"2024-08-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":17936,"price":24.4,"value":437638.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,431 shares of Common Stock underlying the Reporting Person's restricted stock units."}],"balance_after":395923,"source":{"system":"sec-edgar","filing":"0000950170-24-099267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017024099267/ownership.xml","form_type":"4"}},{"id":1437987,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-08T20:39:33.000Z","date":"2024-08-06","kind":"grant","planned":false,"acquired":true,"shares":3160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest in 16 quarterly installments beginning on August 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."}],"balance_after":3160,"derivative":{"exercise_price":24.87,"expiration_date":"2034-08-05","underlying":"Common Stock","underlying_shares":3160},"source":{"system":"sec-edgar","filing":"0000950170-24-094117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017024094117/ownership.xml","form_type":"4"}},{"id":1437986,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22366,"kind":"person","name":"Trimarchi Thomas","position":1,"cik":"0002030813","reported_name":"Trimarchi Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-08-08T20:39:33.000Z","date":"2024-08-06","kind":"grant","planned":false,"acquired":true,"shares":19003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (RSUs) under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan.  The RSUs shall vest in 16 quarterly installments beginning on August 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":413859,"source":{"system":"sec-edgar","filing":"0000950170-24-094117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030813/000095017024094117/ownership.xml","form_type":"4"}}]}